“…PRG1-1 treatment increased the expression levels of iNOS and COX-2, both of which are associated with NO production. The release of NO is involved in many physiological processes, such as vasodilatation (Khan et al, 2017), neurotransmission (Kusek et al, 2017), immune responses (Cinzia, Maria Pia, Angela, & Marco, 2016), and platelet aggregation (Smyth et al, 2017). Furthermore, activated macrophages produce cytokines, including IL-6 and TNF-α, that play important roles in the cellular immune process by aiding in the elimination of abnormal cells (Ying et al, 2009).…”